ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SPRO Spero Therapeutics Inc

1.65
0.04 (2.48%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Spero Therapeutics Inc SPRO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.04 2.48% 1.65 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.63 1.62 1.6494 1.63 1.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/3/202407:05GLOBESpero Therapeutics to Provide Business Update and Report..
28/2/202407:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
26/2/202407:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
09/2/202415:05EDGAR2Form 8-K - Current report
05/2/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202415:50EDGAR2Form 144 - Report of proposed sale of securities
31/1/202415:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
08/1/202405:07EDGAR2Form 8-K - Current report
05/1/202407:11EDGAR2Form 8-K - Current report
05/1/202407:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
04/1/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202407:13EDGAR2Form 8-K - Current report
02/1/202407:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
15/11/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202315:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/11/202315:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/11/202315:13EDGAR2Form 8-K - Current report
13/11/202315:05GLOBESpero Therapeutics Announces Third Quarter 2023 Operating..
13/11/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202305:45IHMARKETNEWSMonday’s Wall Street Highlights: Boeing, Novo Nordisk,..
06/11/202307:05GLOBESpero Therapeutics to Provide Business Update and Report..
01/11/202315:05GLOBESpero Therapeutics to Present at Upcoming November Investor..
01/11/202307:10EDGAR2Form 8-K - Current report
01/11/202307:05GLOBESpero Therapeutics Appoints Esther Rajavelu as Chief..
31/10/202315:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
16/10/202315:01EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202307:28EDGAR2Form 8-K - Current report
29/9/202315:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
20/9/202315:05GLOBESpero Therapeutics to Present at Cantor’s Global Healthcare..
15/9/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202307:05GLOBESpero Therapeutics to Present at H.C. Wainwright 25th Annual..
01/9/202315:11EDGAR2Form ARS - Annual Report to Security Holders
01/9/202315:08EDGAR2Form DEF 14A - Other definitive proxy statements
31/8/202315:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
30/8/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202315:16EDGAR2Form 144 - Report of proposed sale of securities
22/8/202316:27EDGAR2Form PRE 14A - Other preliminary proxy statements
10/8/202315:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202315:17EDGAR2Form 8-K - Current report
10/8/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:05GLOBESpero Therapeutics Announces Second Quarter 2023 Operating..

Su Consulta Reciente

Delayed Upgrade Clock